Printer Friendly Version
COMMITTEE SUBSTITUTE FOR ORDINANCE NO. 040206
Amending Chapter 34, Code
of Ordinances, by repealing Section 34-53, Report of certain diseases and
events required, and 34-56, Persons required to report diseases and conditions,
and enacting new sections of like numbers and subject matters, and enacting a
new Section 34-66, Adults Immunization Program and International Travel
Immunization Program, to add certain disease and condition reporting
requirements and authorizing the director of health to start an Adults
Immunization Program and International Travel Immunization Program.
BE IT ORDAINED BY
THE COUNCIL OF KANSAS CITY:
Section 1. That
Chapter 34, Code of Ordinances of the City of Kansas City, Missouri, is hereby
amended by repealing Section 34-53, Report of certain diseases and events
required, 34-56, Persons required to report diseases and conditions, and
enacting new sections of like numbers and subject matters, and enacting a new
Section 34-66, Adults Immunization Program and International Travel
Immunization Program, to read as follows:
Sec. 34-53. Report of
certain diseases and events required.
(a) Upon
laboratory or clinical confirmation the following diseases must be reported to
the director: animal bites, blastomycosis, campylobacter, chancroid, chlamydia,
Creutzfeldt-Jacob disease, cryptosporidiosis, Cyclospora infection, diphtheria,
ehrlichiosis, Escherichia coli 015:H7, food poisoning (suspected or confirmed;
infectious or toxic), giardia, gonorrhea (all manifestations including
ophthalmia and pelvic inflammatory disease), Haemophilus influenzae (invasive
disease and meningitis), hantavirus, hepatitis A, hepatitis B (including
surface antigen positive pregnant women), hepatitis C, hepatitis D, hepatitis
E, human immunodeficiency virus (HIV asymptomatic or symptomatic, AIDS,
detection of HIV nuclei acid, HIV viral culture, or other test indicating HIV
infection, T-helper (CD4+) lymphocyte count on any person with HIV infection,
and viral load measurement including non-detectable results), influenza,
legionellosis, leptospirosis, listeria, Lyme disease, malaria, measles,
meningitis (aseptic), meningococcal disease (invasive and meningitis), mumps,
mycobacterial infections (active disease and infection, tuberculosis and
mycobacteria other than tuberculosis including leprosy, pulmonary and
non-pulmonary, and positive Mantoux skin tests), nosocomial disease (outbreaks
only), pertussis, poliomyelitis, psittacosis, rabies, Reyes syndrome, Rocky
Mountain spotted fever, rubella, salmonellosis (including typhoid fever),
shigellosis, Staphylococcus aureus (vancomycin resistant only), streptococcal
Group A invasive disease, Streptococcus pneumoniae drug resistant disease,
syphilis (all stages including congenital syndrome), tetanus, trichinosis,
varicella infection (only deaths), vibrio, and yersinia; and others declared
reportable by the director of health; and the occurrence of epidemics or
outbreaks of any illness or disease which may be of public health concern.
(b) Upon
suspicion of or confirmation the following diseases must be reported to the
director: adult respiratory distress syndrome (ARDS) in patients under 50 years
of age (without a contributing medical history), anthrax, botulism,
brucellosis, cholera, encephalitis (arthropod-borne), food poisoning
(infectious or toxic) with multiple cases or resulting in hospitalization,
glanders,
hemorrhagic fevers, plague, Q
fever, ricin poisoning, Severe Acute Respiratory Syndrome (SARS), smallpox or
adverse reaction to smallpox vaccination, staphylococcal enterotoxin B, and T-2
mycotoxins, and tularemia and others declared reportable by the director of
health; and the occurrence of epidemics or outbreaks of any illness or disease
which may be of public health concern.
(c) Incidence of
absenteeism of 20% greater than the daily norm in any public or private school
must be reported to the director; the director shall provide assistance to
schools in the calculation of baseline absenteeism rates and reporting
thresholds.
(d) Unless
otherwise specified, the report shall include the name, time and date of
diagnosis, date of birth, sex, race, address or location, telephone number,
name of the attending physician, name of the disease, condition or finding
diagnosed or suspected, date of onset, name and address of treating facility
(if any), any appropriate laboratory results and other such facts and information
which may be available. For diseases listed in (a) the report shall be made and
received by the director of health within two days of diagnosis in writing or
by telephone, facsimile communication or other rapid communication. For
diseases listed in (b) and (c) the report shall be made and received by the
director within four hours of suspicion or confirmation by telephone, facsimile
communication or other rapid communication.
Sec. 34-56. Persons
required to report diseases and conditions.
(a) The following persons are required to file with
the director of health the reports required in sections 34-53, 34-53.1 and
34-54:
(1) Duly licensed physicians;
(2) Physicians assistants;
(3) Advanced practice nurses;
(4) Every nurse, superintendent, or
principal of a public or private school;
(5) Every owner or any person in
charge of a child care facility;
(6) Administrator of each
institution. The reports filed by such administrator shall not be considered
the divulging of confidential information, and does not relieve the responsible
physician or other person of the duty to report the same case.
(b) Any person in
charge of a plasma center or blood donating center shall report when blood
extracted from a person tests positive for the human immunodeficiency virus or
hepatitis viruses by prevailing laboratory techniques.
(c) Any person in
charge of a clinical laboratory shall report when a laboratory examination of
any specimen derived from the human body yields microscopical, cultural, chemical,
immunological, serological, or other evidence suggestive of those communicable
diseases or disease conditions deemed reportable. This reporting requirement
also applies to laboratory specimens sent to another laboratory for analysis or
evaluation. Isolates of the following specimens must be submitted to the
Missouri Department of Health Laboratory for epidemiological or confirmation
purposes:
(1) anthrax
(2) cholera
(3) diphtheria
(4) Escherichia coli 0157:H7
(5) Haemophilus influenzae from
invasive disease
(6) malaria
(7) measles
(8) tuberculosis
(9) Neisseria meningitidis from
invasive disease
(10) pertussis
(11) plague
(12) salmonella, all species
(13) shigella, all species
(14) Staphylococcus aureus,
vancomycin resistant strains only
(15) Severe Acute Respiratory
Syndrome
Submission of specimens does
not relieve the person in charge of a clinical laboratory from the reporting
requirement.
(d) It shall be
unlawful for any person to fail to make a report required in this article
within the applicable reporting time.
Sec. 34-66. Adults
Immunization Program and International Travel Immunization Program.
The director is
authorized to establish an adult immunization program and an international
travel immunization program to provide immunization for prevention of disease
and for post-exposure prophylaxis in accordance with established guidelines and
recommendations from the Centers for Disease Control and Prevention (CDC) and to
set an appropriate fee schedule to offset the costs of the programs.
_____________________________________________
Approved
as to form and legality:
___________________________________
James
M. Brady
Assistant
City Attorney